Professor Sarah Gilbert (University of Oxford) presenting the 2024 UCL Prize Lecture in Life and Medical Sciences on 'Vaccine development during and after the pandemic.' About Professor Sarah Gilbert, DBE, FRS, FMedSci Sarah Gilbert is a Professor of Vaccinology in the Pandemic Sciences Institute at Oxford University. She works on viral vectored vaccine development, with projects on influenza, Nipah, MERS, and Lassa. Working with colleagues on the Old Road Campus in Oxford, she is able to take novel vaccines from design through GMP manufacturing to clinical development, with a particular interest in the rapid transfer of vaccines into GMP manufacturing and first in human trials. She was the Oxford Project Leader for ChAdOx1 nCoV-19, also known as Vaxevria/Covishield, which was estimated to have saved 6.3 million lives in its first year of use.

17

12/12/2024

Dr Steffi Frank works on the design and industrial application of enzyme localisation technologies with the aim to synthesise bio-therapeutic proteins and small molecule drugs. Her teaching is in the areas of Biochemistry, Molecular Biology, Biotechnology and Synthetic Biology.

11

8/5/2022

Claire Elliott, GP at Ridgemount Practice, and UCL public health experts Professor Ibrahim Abubakar (Professor of Infectious Disease Epidemiology) and Professor Robert Aldridge (Professor of Public Health Data Science) explain how we know the COVID-19 vaccine is safe

24223

6/18/2021

We asked Claire Elliott, GP at Ridgemount Practice and UCL public health experts Professor Ibrahim Abubakar (Professor of Infectious Disease Epidemiology) and Professor Robert Aldridge (Professor of Public Health Data Science) some questions about how the COVID-19 vaccine works.

24247

6/18/2021

Dr Jasmine Samaras and Professor Martina Micheletti discuss the challenges involved in making a vaccine safely, cheaply and sustainably and, how technologies could revolutionise the industry.

102

5/27/2021

Seminar 3 - Vaccine Developent, Tuesday 4th May, 11am-12pm The session will be hosted by Professor Paul Dalby (Biologics TIN Chair), and includes an introduction to the Biologics Therapeutic Innovation Network (TIN) and the opportunities provided through the TIN, followed by two speakers from the Biologics community at UCL: Speakers: Prof Martina Micheletti Prof Delmiro Fernandez-Reyes To keep updated with activities and opportunities from the Biologics TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter

34

5/5/2021

When is a COVID-19 vaccine likely to be available? Dr Jennifer Rohn, Principal Research Fellow in the UCL Division of Medicine, explains... Find out how UCL is supporting efforst to tackle the pandemic by advising policymakers and researching new ways of tackling the virus: https://www.ucl.ac.uk/covid-19-research/

448

4/15/2020